This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Adalimumab was superior to cyclosporine in preventing uveitis relapse in patients with severe Behçet disease already on corticosteroid therapy, according to randomized, open-label trial results.
Medscape Medical News